Direkt zum Inhalt
Merck

Telepsychiatry: videoconferencing in the delivery of psychiatric care.

The American journal of psychiatry (2013-03-02)
Jay H Shore
ZUSAMMENFASSUNG

The provision of psychiatric treatment via live interactive videoconferencing, frequently termed telepsychiatry, is a viable option for psychiatrists to provide care to individual patients, populations, and communities faced with limited access and to move the point of care delivery into patients' living environments. Psychiatric providers new to videoconferencing should not be intimidated by the technology or its encompassing logistics, but they do need to develop an awareness of the salient regulatory, administrative, and clinical issues that arise in the practice of videoconferencing-based telepsychiatry. This article provides an overview of the current evidence base in telepsychiatry and reviews administrative and clinical issues in videoconferencing-based treatment. These points are then highlighted in a case example.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Prazosin -hydrochlorid, ≥99.0% (HPLC)
Sigma-Aldrich
Sertralin -hydrochlorid, ≥98% (HPLC)
Supelco
Sertraline hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sertralin für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Sertralin -hydrochlorid, European Pharmacopoeia (EP) Reference Standard
Sertralin für die Systemeignung, European Pharmacopoeia (EP) Reference Standard